Pill Identifier App

OPI 409 (Chlordiazepoxide and Clidinium 5 mg / 2.5 mg)

Pill imprint OPI 409 has been identified as Chlordiazepoxide hydrochloride and clidinium bromide 5 mg / 2.5 mg.

Chlordiazepoxide/clidinium is used in the treatment of irritable bowel syndrome; enterocolitis; peptic ulcer and belongs to the drug class anticholinergics/antispasmodics. There is positive evidence of human fetal risk during pregnancy. Chlordiazepoxide/clidinium 5 mg / 2.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for OPI 409

Chlordiazepoxide hydrochloride and clidinium bromide 5 mg / 2.5 mg OPI 409
Chlordiazepoxide hydrochloride and clidinium bromide
Imprint:
OPI
409
Strength:
5 mg / 2.5 mg
Color:
Green
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Anticholinergics/antispasmodics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Oceanside Pharmaceuticals, Inc.
National Drug Code (NDC):
68682-0409
Inactive Ingredients:
corn starch
lactose
magnesium silicate
methylparaben
propylparaben
potassium sorbate
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Green No. 3

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)